EBAC
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
EBAC
Delisted
EBAC was delisted on the 2nd of March, 2023.
41 hedge funds and large institutions have $55.2M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+10
Holders Change %
+32.26%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
5
Reduced
1
Closed
–
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
-$6K
Top Buyers
1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$4.87M |
2 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
+$2.2M |
3 |
D.E. Shaw & Co
New York
|
+$1.89M |
4 |
CCM
CAAS Capital Management
New York
|
+$935K |
5 |
GF
Gabelli Funds
Rye,
New York
|
+$711K |
Top Sellers
1 |
Millennium Management
New York
|
-$183K |